Key facts
- Akadeum Life Sciences’s last known valuation is $32.7M (Sep 2021).
- It has raised $55.4M across 6 recorded rounds; the latest was Early Stage VC ($5.6M) in Apr 2025.
- Notable investors include US National Science Foundation, Western Technology Investment, Hemisphere Ventures, Michigan Rise, Invest Detroit Ventures — 36 tracked in total.
- Akadeum Life Sciences has filed 12 Form Ds with the SEC since 2014, most recently Apr 2025 ($5.6M sold to 35 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 36 names
- ·Watchlist + deal alerts for Akadeum Life Sciences
Funding rounds
6 roundsAbout Akadeum Life Sciences
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The company's products are based on buoyancy-activated cell sorting that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.
- Sector
- Healthcare
- HQ
- Ann Arbor, MI, United States
- Founded
- 2014
- Employees
- 24
- Website
- akadeum.com/
- Ownership
- Privately Held (backing)
Akadeum Life Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Akadeum Life Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Akadeum Life Sciences in its N-PORT filings yet. We sweep new filings monthly.